Status message

Active context: kki_bg_colors_yellow

Evaluation of data obtained from a Phase III trial to evaluate Lorenzo's oil in adults with X-linked adrenoleukodystrophy

Principal Investigator:

This study will evaluate data collected in a placebo-controlled study of Lorenzo's oil in adult men and women with X-linked adrenoleukodystrophy. This study was originally run from 2005-2008 under Dr. Hugo Moser and Dr. Gerald Raymond. There continues to be aspects of the quantitative sensorimotor examination in conjunction with the quanititative MRI data that are being explored. Two papers are presently in the final stages of development and we wish to be able to provide additional analysis in the review process.

The prior version NA_0052395 was allowed through an oversight to terminate. The present version will have Dr. Kathleen Zackowski as the principal investigator since she will have the primary interest in completing the data analysis.

Bradley L. Schlaggar, M.D., Ph.D., Named President and CEO of Kennedy Krieger Institute

We’re thrilled to welcome Bradley L. Schlaggar, M.D., Ph.D., to the Kennedy Krieger family as our next President and CEO.
Learn more.


Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.